Summary
Guardant Health, Inc. (GH) filed an 8-K on February 23, 2023, to announce its financial results for the fiscal quarter and year ended December 31, 2022. The primary purpose of this filing is to furnish the press release containing these results, which provides investors with a summary of the company's recent performance. While the 8-K itself doesn't detail the financial figures, it directs readers to the furnished press release for this critical information. Investors should refer to the press release (Exhibit 99.1) for specifics on revenue, earnings per share, and any forward-looking guidance provided by Guardant Health. This filing serves as the official notification of these results, and the press release will contain the most up-to-date information regarding the company's financial standing and outlook for the period.
Key Highlights
- 1Guardant Health announced its financial results for the fourth quarter and full year ended December 31, 2022.
- 2The 8-K filing's primary purpose is to furnish the press release containing the financial results.
- 3Investors are directed to the press release (Exhibit 99.1) for detailed financial performance data.
- 4The filing incorporates the press release by reference.
- 5Information furnished in the 8-K is not considered 'filed' for Section 18 of the Exchange Act.
- 6The press release contains forward-looking statements as typically disclosed in such announcements.